Examination Report |
1 | TM-1 | 04 Mar 2013 |
10 | Order | 18 Jun 2018 |
11 | Certificate | 19 Jun 2018 |
12 | TM-P(CHANGE NAME OF REGISTERED PROP/USER) | 20 Sep 2021 |
13 | TM-R(RENEWAL OF TRADE MARK) | 24 Sep 2022 |
14 | Letters related to POST REGISTRATION | 08 Sep 2023 |
15 | Letters related to POST REGISTRATION | 21 Sep 2023 |
2 | Additional Representation Sheet | 04 Mar 2013 |
3 | Reply to Exam Report (MIS-R) | 25 Aug 2014 |
4 | Journal Copy | 30 May 2016 |
5 | TM-5 | 27 Sep 2016 |
6 | Forwarding Letter for TM-5 | 24 Nov 2016 |
7 | TM-6 | 01 Feb 2017 |
8 | Forwarding Letter for TM-6 | 05 May 2017 |
9 | Hearing Notice | 10 May 2018 |
1 | Opposition Notice | 4088507 | 13 Oct 2016 | |
2 | Generate Report | 6319503 | 08 May 2018 | |
3 | Decission Forwarding Letter | 6517769 | 18 Jun 2018 | |
4 | RENEWAL INTIMATION LETTER | 14147792 | 27 Sep 2022 | |
5 | Scrutiny Report | 15734888 | 6090410 | 31 Jul 2023 |
Referis was applied on 04 March 2013.
Trademark application was filed by MAIVA PHARMA.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Registered.
Listed application Id of Referis is 2488964.
Trademark attorney of the Referis is S.Balajanaki.
Referis is a WORD as per IP India data.